MICHÈLE SAUNDERS CLAVERY, president of the Alzheimer's Association of TT, says from the increased number of phone calls, e-mails and messages from...

New research has found a way to diagnose Alzheimer’s disease (AD) earlier by analyzing biomarkers in blood. This could help reduce the effects of...

THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...

Early one morning in February 2023, before the sun rose over Phoenix, Ravi Coutinho went on a walk and, for a brief moment, thought about hurling his...

Early one morning in February 2023, before the sun rose over Phoenix, Ravi Coutinho went on a walk and, for a brief moment, thought about hurling his...

They were developed as diabetes drugs, then their potential for promoting significant weight loss became apparent. And now study after study seems to...

Graeme felt it was 'the end of the line' for him after his previous treatments failed when he was offered the new 'lifeline' drug.

Graeme felt it was 'the end of the line' for him after his previous treatments failed when he was offered the new 'lifeline' drug.